Dongkwang Prucalopride 1 mg Tablet (Prucalopride Succinate)
Prucalopride Succinate 1.321mg
Tablet · Prescription medication
Dongkwang Pharmaceutical Co., Ltd.
MFDS item code 201906818 · Approved 2019.09.25
This product's status changed to Expired on 2024.09.25. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of chronic constipation symptoms
This medicine is used for the treatment of chronic constipation in adults who do not experience improvement with laxatives. It assists patients suffering from chronic constipation and promotes bowel movements while improving defecation activities. Regular use is effective in alleviating constipation symptoms.
This medication is administered orally and can be taken at any time of the day regardless of meals. Adults should take 2 mg once daily. Elderly patients aged 65 and older should start with an initial dose of 1 mg once daily, which may be increased to 2 mg once daily if necessary. Patients with severe renal impairment (GFR < 30 ml/min/1.73 m2) should take 1 mg once daily. Patients with hepatic impairment among those with moderate liver dysfunction should receive 1 mg once daily.
This medication should not be used in certain patients. For instance, individuals who are allergic to this drug's active ingredients or additives should not take it. Patients with severely impaired kidney function or structural problems in their intestines should also avoid this medication. Additionally, it is not suitable for individuals with genetic disorders that affect lactose breakdown. Since this drug is primarily excreted by the kidneys, patients with severely reduced renal function should use it cautiously and at a reduced dose. Patients with other serious conditions affecting the liver, heart, lungs, or nervous system should also use it under careful medical supervision. Caution is advised when using this drug in patients with a history of heart rhythm disorders or ischemic heart disease, as well as in those with severely impaired liver function who should take a reduced dose. Care is also needed when taking this medication with other drugs that may affect heart rhythm. Common side effects that may occur after administration include headache, nausea, diarrhea, and abdominal pain, and these symptoms generally appear in the early stages of treatment and diminish over time. Symptoms such as fatigue, dizziness, palpitations, vomiting, and indigestion have also been reported. If new palpitations occur, it is essential to consult a physician. There is limited experience with the use of this drug during pregnancy, thus it is not recommended, and fertile women should employ effective contraception during treatment. During breastfeeding, this drug may be secreted in breast milk, but it is not recommended although there is a low likelihood of significant effects on infants. It is advisable not to use this drug in children or adolescents under 18 years of age. In case of overdose, symptoms such as headache, nausea, and diarrhea may occur, and since no specific antidote exists, appropriate treatment should be provided according to the symptoms. This medication may cause dizziness or fatigue on the first day of use, so caution should be exercised when driving or operating machinery. Finally, this medication should be stored out of reach of children and kept in its original container away from moisture.
Chest discomfort, ventricular premature contractions
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a container that blocks light and air, and care should be taken to prevent exposure to moisture. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius.
White to off-white round film-coated tablets
28 tablets (14 tablets/PTP * 2)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Prucalopride Succinate 1.321mg
Tablet · Prescription medication
Dongkwang Pharmaceutical Co., Ltd.

Prucalopride Succinate 1.321mg
Tablet · Prescription medication
Hanmi Menarini Co., Ltd.

Prucalopride Succinate 2.642mg
Tablet · Prescription medication
Korea Menarini Co., Ltd.
Prucalopride Succinate 1.321mg
Tablet · Prescription medication
Genewon Science Co., Ltd.
Prucalopride Succinate 2.642mg
Tablet · Prescription medication
Genewell Science Co., Ltd.

Prucalopride Succinate 2.642mg
Tablet · Prescription medication
Yooyoung Pharmaceutical Co., Ltd.

Prucalopride Succinate 1.321mg
Tablet · Prescription medication
YuYoung Pharmaceutical Co., Ltd.
Prucalopride Succinate 1.321mg
Tablet · Prescription medication
Huons Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.